Jin-Wou Kim

Jin-Wou Kim


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 1993 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SCS C Chan
S C Chan
JKJin-Wou Kim
Jin-Wou Kim
WHW R Henderson
W R Henderson
JHJ M Hanifin
J M Hanifin
The monocyte-derived inflammatory mediator, prostaglandin E2 (PGE2), can reduce IFN-gamma production, and this in turn may relate to IL-4 up-regulation of IgE synthesis and impaired delayed hypersensitivity in atopy. These abnormalities may relate to the cyclic nucleotide dysregulation in atopic dermatitis (AD), where monocyte cyclic AMP-phosphodiesterase (PDE) activity is increased and the consequent reduction in cAMP levels allows increased inflammatory responsiveness. In this study, we assessed the relationship between PGE2 and IFN-gamma production along with abnormal PDE activity in AD monocytes. Blood mononuclear leukocytes (MNL) from normal and AD donors were cultured for 24 hours, and supernatants were assayed for PGE2 and IFN-gamma by RIA. Spontaneous PGE2, but not leukotriene C4 release, was significantly increased in AD MNL (p < 0.05), although IFN-gamma levels were reduced (p < 0.05). In contrast, purified AD T cells, after removal of PGE2-producing monocytes, produced levels of IFN-gamma significantly higher than in normal T cell cultures. Inhibition of PGE2 synthesis by indomethacin caused increased IFN-gamma production by MNL cultures. We noted a strong negative correlation (r = 0.77) between PDE activity and IFN-gamma production in MNL cultures. We speculate that abnormal cyclic nucleotide metabolism caused by increased PDE activity may allow elevated levels of PGE2 production by AD monocytes. This study demonstrates a regulatory interaction between monocytes and T cells in AD and suggests that PGE2 may be an extracellular messenger between these cells to modulate IFN-gamma production.

1 February 2002 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
HLHyun-Jeong Lee
Hyun-Jeong Lee
SHSeog-Jun Ha
Seog-Jun Ha
JLJoo-Han Lee
Joo-Han Lee
JKJin-Wou Kim
Jin-Wou Kim
HKHyung-Ok Kim
Hyung-Ok Kim
DWDavid A. Whiting
David A. Whiting

21 January 2011 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
KLKyung Ho Lee
Kyung Ho Lee
KCKyung‐Ah Cho
Kyung‐Ah Cho
JKJin‐Young Kim
Jin‐Young Kim
JBJi‐Hae Baek
Ji‐Hae Baek
SWSo‐Youn Woo
So‐Youn Woo
JKJin-Wou Kim
Jin-Wou Kim

1 December 2003 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SCSoo-Cheon Chae
Soo-Cheon Chae
JSJu-Hee Song
Ju-Hee Song
YLYong-Chul Lee
Yong-Chul Lee
JKJin-Wou Kim
Jin-Wou Kim
HCHun-Taeg Chung
Hun-Taeg Chung

1 December 2003 in Human Immunology
Verified
Journal Article
Closed access
SCSoo-Cheon Chae
Soo-Cheon Chae
JSJu-Hee Song
Ju-Hee Song
JHJin-Chul Heo
Jin-Chul Heo
YLYong-Chul Lee
Yong-Chul Lee
JKJin-Wou Kim
Jin-Wou Kim
HCHun-Taeg Chung
Hun-Taeg Chung

1 January 2010 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
MKMin Joo Kim
Min Joo Kim
TKTae Wook Kang
Tae Wook Kang
ECEun Ah Cho
Eun Ah Cho
Hei Sung KimHei Sung Kim
Hei Sung Kim
JMJung Ah Min
Jung Ah Min
YPYoung Min Park
Young Min Park
Kim MJ, et al. J Korean Med Sci. 2010 Dec;25(12):1828-1830. http://dx.doi.org/10.3346/jkms.2010.25.12.1828